,trastuzumab deruxtecan
astrazeneca,daiichi sankyo,jw therapeutics
['destiny,breast,4', 'breast', 'trastuzumab', 'destiny-breast04', 'jw']
christine sadlowski talks with dr. shanu modi about the destiny-breast04 study, which looked at trastuzumab deruxtecan for advanced her2-low breast cancer. #asco22 #breastcancer 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.